Breaking News

Coronavirus Consortium Accelerates Immunotherapy Research

To leverage Carterra’s LSA platform to screen hundreds of antibodies in a few days as CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Carterra Inc., a high-throughput antibody screening and characterization tools company, and La Jolla Institute for Immunology (LJI), entered an agreement that will leverage Carterra’s LSA platform to screen hundreds of antibodies in just a few days allowing Coronavirus Immunotherapy Consortium (CoVIC) to move therapeutic candidates to the clinic as early as this summer.   LJI has been awarded a $1.73 million grant by the Bill & Melinda Gates Foundation to establish a Coronavirus Immunother...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters